Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 1;62(1):1-10.
doi: 10.2169/internalmedicine.8417-21. Epub 2021 Oct 19.

Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment

Affiliations

Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment

Yoshikazu Kinoshita et al. Intern Med. .

Abstract

Eosinophilic gastrointestinal diseases are delayed-type chronic allergic disorders that show gastrointestinal eosinophil dense infiltration, with an exaggerated Th2-type immune reaction considered to be an important mechanism. These diseases can be roughly divided into two types: eosinophilic esophagitis, mainly found in young and middle-aged men, and eosinophilic gastroenteritis, which is found in both genders equally. A diagnosis of eosinophilic esophagitis is suspected when characteristic endoscopic findings, including longitudinal furrows and rings, are noted. However, characteristic endoscopic abnormalities are rarely found in cases with eosinophilic gastroenteritis, so multiple biopsy sampling from the apparently normal gastrointestinal mucosal surface is important for making an accurate diagnosis. The administration of systemic glucocorticoid is the standard treatment for eosinophilic gastroenteritis, while acid inhibitors and topical glucocorticoid swallowing therapy are effective for eosinophilic esophagitis. Anti-cytokine therapies for eosinophilic gastrointestinal diseases are currently under development.

Keywords: allergy; elimination diet; endoscopy; proton pump inhibitor.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no Conflict of Interest (COI).

Figures

Figure 1.
Figure 1.
Influence of genetic and environmental factors on the development of eosinophilic gastrointestinal diseases.
Figure 2.
Figure 2.
Classification of eosinophilic gastrointestinal diseases.
Figure 3.
Figure 3.
Maximal eosinophil infiltration in different segments of the gastrointestinal tract in a normal healthy individual.
Figure 4.
Figure 4.
Flowchart of the diagnosis and treatment of eosinophilic esophagitis.
Figure 5.
Figure 5.
Flowchart of the diagnosis and treatment of eosinophilic gastroenteritis.

References

    1. Cianferoni A. Eosinophilic esophagitis and other eosinophilic disorders of the gastrointestinal tract. Pediatr Allergy Immunol Suppl 24: 25-27, 2020. - PubMed
    1. Kinoshita Y, Ishimura N, Oshima N, Ishihara S. Systematic review: eosinophilic esophagitis in Asian countries. World J Gastroenterol 21: 8433-8440, 2015. - PMC - PubMed
    1. Yamamoto M, Nagashima S, Yamada Y, et al. . Comparison of non-esophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: a nationwide survey. J Allergy Clin Immunol Pract 3339-3349, 2021. - PubMed
    1. Kinoshita Y, Oouchi S, Fujisawa T. Eosinophilic gastrointestinal diseases - Pathogenesis, diagnosis, and treatment. Allergol Int 68: 420-429, 2019. - PubMed
    1. Kawashima K, Ishihara S, Masuhara M, et al. . Development of eosinophilic esophagitis following sublingual immunotherapy with cedar pollen extract: a case report. Allergol Int 67: 515-517, 2018. - PubMed

Substances

Supplementary concepts